ERIS Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
566.07
490.49
508.78
467.61
403.80
Other Income Qtr Cr15.154.203.480.991.00
Operating Revenues Qtr550.93486.30505.30466.62402.80

*All values are in Cr.

Operating Expenses Qtr
402.49
310.79
324.16
296.88
283.90
Operating Profit Qtr
148.43
175.51
181.14
169.75
118.89
EBIDT Qtr Cr
163.58
179.71
184.63
170.73
119.90
Depreciation Qtr
53.90
45.72
42.09
40.89
35.13
Net Profit Qtr
70.96
102.74
123.43
94.86
65.42
Basic EPS Qtr
5.22
7.55
9.08
6.97
4.81
Open Demat Account
or Resume your Application
+91 -

personImage